English
中文繁體
中文简体

Dark
Light

Open Account

HK Stock MarketDetailed Quotes

02181 MABPHARM-B

Watchlist

0.430
+0.020+4.88%

Market Closed May 2 16:08 CST

1.77BMarket Cap-12.65P/E (TTM)

MABPHARM-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:CNY

2024/FY

Stock NameRevenueRatio

来自销售药品的收入215.2M83.34%

中国内地独家推广许可权收入30.53M11.82%

合同研发生产协议收入12.44M4.82%

提供合约服务的收入71K0.03%

Product Currency:CNY

2024/FY

Stock NameRevenueRatio

来自销售药品的收入215.2M83.34%

中国内地独家推广许可权收入30.53M11.82%

合同研发生产协议收入12.44M4.82%

提供合约服务的收入71K0.03%

Region Currency:CNY

2024/FY

Stock NameRevenueRatio

The mainland of China258.23M100.00%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.